Glutathione S-transferase omega in COPD patients
Author Information
Author(s): Harju Terttu H, Peltoniemi Mirva J, Rytilä Paula H, Soini Ylermi, Salmenkivi Kaisa M, Board Philip G, Ruddock Lloyd W, Kinnula Vuokko L
Primary Institution: University of Oulu
Hypothesis
GSTO may participate in the maintenance of GSH not only intracellularly, but also in the extracellular space and this may be modulated by oxidative stress.
Conclusion
GSTO1-1 is abundant in the alveolar macrophages, but it is also present in extracellular fluids and in airway secretions, the levels being decreased in COPD.
Supporting Evidence
- GSTO1-1 was mainly expressed in alveolar macrophages.
- Levels of GSTO1-1 were significantly lower in the sputum supernatants of COPD patients than in non-smokers.
- GSTO1-1 could be detected in extracellular fluids including sputum supernatants and bronchoalveolar lavage fluid.
Takeaway
This study looked at a protein called GSTO1-1 in the lungs of people with COPD and found that it is lower in those patients, which might affect their lung health.
Methodology
The study used immunohistochemistry and Western blot analysis on lung and sputum specimens from COPD patients and controls.
Limitations
The study had a limited number of cases and high variability in macrophage numbers.
Participant Demographics
The study included non-smokers, smokers, and COPD patients with varying severities.
Statistical Information
P-Value
0.003
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website